Clinical Monitoring of Therapeutic Drugs

Aherne G. W. Piall E. M. Marks V. (1977). Development and application of a radioimmunoassay for methotrexate. British Journal of Cancer, 36, 608–617.

Aherne G. W. Piall E. Marks V. Mould G. White W. F. (1978). Prolongation and enhancement of serum methotrexate concentrations by probenecid. British Medical Journal, 1, 1097–1099.

Aronson J. K. Grahame-Smith D. G. Wigley F. M. (1978). Monitoring digoxin therapy: the use of of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity Quarterly Journal of Medicine, NS47, No. 186, 111–122.

Baastrup P. C. Schou M. (1967). Lithium as a prophylactic agent. Archives of General Psychiatry, 16, 162–172.

Baylis E. M. Crowley J. M. Preece J. M. Sylvester P. E. Marks V. (1971). Influence of folic acid on blood-phenytoin levels Lancet, i, 62–64.

Billings R. Grahame R. Marks V. Wood P. J. Taylor A. (1975). Blood and urine gold levels during chrysotherapy for rheumatoid arthritis. Rheumatology and Rehabilitation, 14, 13–18.

Brodie B. B. Reid W. D. (1971). The value of determining the plasma concentration of drugs in animals and man. In Fundamentals of Drug Metabolism and Disposition, edited by La Du B. N. Mandel H. G. Way E. L. , pp.328–339. Williams and Wilkins, Baltimore.

Currie S. H. (1974). Drug Disposition and Pharmacokinetics: with a consideration of pharmacological and clinical relationships. Blackwell Scientific, Oxford.

Curtis E. G. Patel J. A. (1978). Enzyme multiplied immunoassay technique: a review. Critical Reviews in Clinical Laboratory Science, 9, 303–320.

Danhof M. Breimer D. D. (1978) Therapeutic drug monitoring in saliva. Clinical Pharmacokinetics, 3, 39–57.

Hawk G. L. (1979). Biological/Biomedical Applications of Liquid Chromatography. Marcel Dekker, New York.

Hestbeck J. Aurell M. (1979). Lithium-induced uraemia. Lancet, 1, 212–213.

Holland W. W. Whitehead T. P. (1974) Value of new laboratory tests in diagnosis and treatment. Lancet, 2, 391–394.

Horning M. G. Brown L. Nowlin J. Lertratanangkoon K. Kellaway P. Zion T. E. (1977). Use of saliva in therapeutic drug monitoring. Clinical Chemistry, 23, 157–164.

Hullin R. P. Coley V. P. Birch N. J. Thomas T. H. Morgan D. B. (1979). Renal function after long term treatment with lithium. British Medical Journal, 1, 1457–1459.

Ingelfinger J. A. Goldman P. (1976). The serum digitalis concentration—does it diagnose digitalis toxicity?. New England Journal of Medicine, 294, 867–870.

Koch-Weser J. (1972). Serum drug concentrations as therapeutic guides. New England Journal of Medicine, 287, 227–231.

Koch-Weser J. (1975). The serum level approach to individualization of drug dosage. European Journal of Clincial Pharmacology, 9, 1–8.

Kragh-Sorensen P. (1975). The relationship between nortriptyline plasma levels and clinical effects. Proceedings of the Royal Society of Medicine, 68, 99–102 (Section of Psychiatry, pp. 1–4).

Kutt H. Penry J. K. (1974). Usefulness of blood levels of anti-epileptic drugs. Archives of Neurology, 31, 283–288.

La Du B.N. Mandel H.G. Way E. L. (1971). Fundamentals of Drug Metabolism and Drug Disposition. Williams and Wilkins, Baltimore.

Lehmann H. Liddell J. (1972). The cholinesterase variants. In The Metabolic Basis of Inherited Diseases, edited by Stanbury J. B. Wyngaarden J. B. Fredrickson D. S. , 3rd edition, pp.1730–1736. McGraw-Hill, New York.

McCormick W. Ingelfinger J. A. Isakson G. Goldman P. (1978). Errors in measuring drug concentrations. New England Journal of Medicine, 299, 1118–1121.

Marks V. (1979). New developments in immunoassays for therapeutic drug monitoring. Antiobiotics and Chemotherapy, 26, 16–26.

Marks V. Lindup W. E. Baylis E. M. (1973). Measurement of therapeutic agents in blood. Advances in Clinical Chemistry, 16, 47–109.

Mould G. P. Aherne G. W. Morris B. A. Teale J. D. Marks V. (1977). Radioimmunoassay of drugs and its clinical application. European Journal of Drug Metabolism and Pharmacokinetics, 4, 171–184.

Mould G. Morris B. A. Marks V. Malan P. G. Ekins R. (1979). A quality control scheme for digoxin. In Abstracts of Papers and Posters—Third European Congress of Clinical Chemistry, Brighton 1979.

Mucklow J. C. Bending M. R. Kahn G. C. Dollery C. T. (1978). Drug concentration in saliva. Clinical Pharmacology and Therapeutics, 24, 563–570.

Munro-Faure A. D. Fox J. Fowle A. S. E. Johnson B. F. Lader S. (1974). Recognition of variable bioavailability as an international problem: a review of earlier studies. Postgraduate Medical Journal, 50, Supplement 6, 14–17.

Munster D. J. Lever M. Walmsley T. A. Desmond F. B. (1978). Design of interlaboratory surveys of drug analyses: a pilot program with salicylate, diphenylhydantoin, digoxin, and ethanol. Journal of Analytical Toxicology, 2, 250–256.

Pippinger C. E. Paris-Kutt H. Penry J. K. (1977). Proficiency testing in determination of antiepileptic drugs. Journal of Analytical Toxicology, 1, 118–122.

Reynolds E. H. Chadwick D. Galbraith A. W. (1976). One drug (phenytoin) in the treatment of epilepsy. Lancet, 1, 923–926.

Richens A. (1976). Quality control of drug estimations. Acta Neurologica Scandinavica, Supplement, 75, 81–84.

Richens A. Dunlop A. (1975). Serum-phenytoin levels in management of epilepsy. Lancet, 2, 247–248.

Rowland M. (1978). Drug administration and regimens. In Clinical Pharmacology: Basic Principles in Therapeutics, 2nd edition, edited by Melmon M. L. Morelli H. F. , pp.25–70. Macmillan, New York.

Schou M. Baastrup P. C. Grof P. Weis P. Augst J. (1970). Pharmacological and clinical problems of lithium prophylaxis. British Journal of Psychiatry, 116, 615–619.

Schou M. Amisden A. Baastrup P. E. (1971). The practical management of lithium treatment. British Journal of Hospital Medicine, 6, 53–60.

Sheiner L. B. Tozer T. N. (1978). Clinical pharmacokinetics: the use of plasma concentrations of drugs. In Clinical Pharmacology: Basic Principles in Therapeutics, 2nd edition, edited by Melmon K. L. Morelli H. F. , pp.71–109. Macmillan, New York.

Stewart M. J. (1975). Phenytoin dosage. Lancet, 2, 278.

Tyrer J. H. Eadie M. J. Sutherland J. M. (1970). Outbreak of anticonvulsant intoxication in an Australian city. British Medical Journal, 4, 271–273.

Werner M. Sutherland E. W. Abramson F. P. (1975). Concepts for the rational selection of assays to be used in monitoring therapeutic drugs. Clinical Chemistry, 21, 1368–1371.

Williams R. T. (1946). Detoxication Mechanism. Chapman and Hall, London.